Transcode Therapeutics RNAZ
NASDAQ RNAZ
$1.57 +0.03 (+1.62%)
At close: Oct 2, 2026 · 4:00 PM EDT

Transcode Therapeutics (RNAZ) Cash & Equivalents (2020 - 2026)

Updated

Transcode Therapeutics (RNAZ) posted Cash & Equivalents of $8.4 million for Q2 2026, up 13.5% from $7.4 million a year earlier but down 34.6% from the prior quarter.

Analysis

Transcode Therapeutics (RNAZ) Cash & Equivalents (2020 - 2026) Analysis & Trends

At the end of FY2025, Transcode Therapeutics' Cash & Equivalents came in at $17.81 million, up 206.5% from FY2024.

  • Annual Cash & Equivalents shows a five-year compound annual growth rate of 84.7% (FY2020 to FY2025).
  • In prior years, Transcode Therapeutics' Cash & Equivalents was $5.81 million in FY2024 (+110.0%), $2.77 million in FY2023 (-44.3%), $4.97 million in FY2022 (-76.1%) and $20.83 million in FY2021.
  • Quarterly Cash & Equivalents has run from a low of $1.62 million in Q1 2023 to a high of $22.5 million in Q3 2021 over five years.
  • On a year-over-year basis, Cash & Equivalents has increased in each of the last seven quarters, with growth averaging 71.1% over the last eight quarters.
  • The strongest year-over-year quarter for Cash & Equivalents in the past five years was Q4 2025, with growth of 206.5%; the weakest was Q1 2023, with a decline of 90.4%.
  • According to Business Quant data, Cash & Equivalents for the three prior quarters was $12.84 million (Q1 2026), $17.81 million (Q4 2025) and $2.84 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Equiv. (Qtr)
1 Eli Lilly 1,082.65 Bn 1,051.23 Bn 19.71 Bn 8.95 Bn
2 Johnson & Johnson 623.68 Bn 542.21 Bn 17.26 Bn 20.42 Bn
3 AbbVie 459.43 Bn 432.59 Bn 12.70 Bn 6.57 Bn
4 Merck 354.80 Bn 309.23 Bn 12.21 Bn 6.85 Bn
5 Novartis Ag 269.16 Bn 225.03 Bn 11.24 Bn 7.62 Bn
6 Astrazeneca 244.40 Bn 217.97 Bn 12.86 Bn 4.89 Bn
7 Amgen 220.17 Bn 175.57 Bn 7.24 Bn 13.99 Bn
8 Gilead Sciences 183.05 Bn 157.16 Bn 6.22 Bn 3.18 Bn
9 Pfizer 160.27 Bn 107.22 Bn 10.94 Bn 976.00 Mn
10 Transcode Therapeutics 1.55 Mn 1.55 Mn - 8.40 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 8.40 Mn
Mar 31, 2026 12.84 Mn
Dec 31, 2025 17.81 Mn
Sep 30, 2025 2.84 Mn
Jun 30, 2025 7.40 Mn
Mar 31, 2025 11.60 Mn
Dec 31, 2024 5.81 Mn
Sep 30, 2024 1.90 Mn
Jun 30, 2024 3.40 Mn
Mar 31, 2024 4.91 Mn
Dec 31, 2023 2.77 Mn
Sep 30, 2023 7.50 Mn
Jun 30, 2023 3.60 Mn
Mar 31, 2023 1.62 Mn
Dec 31, 2022 4.97 Mn
Sep 30, 2022 8.80 Mn
Jun 30, 2022 13.44 Mn
Mar 31, 2022 16.90 Mn
Dec 31, 2021 20.83 Mn
Sep 30, 2021 22.50 Mn
API Access

Transcode Therapeutics Cash & Equivalents API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=RNAZ&period=max&api_key=YOUR_API_KEY